The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis)

Reumatismo

Volumn 63, Issue 4, 2011, Pages 230-237

  Busso, Nathalie ^a   Ea, H K ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b INSERM   (France)

Author keywords

Calcium pyrophosphate crystals; Danger signals; Gout; IL1; Inflammasome; Pseudogout; Syk kinase; Urate

Indexed keywords

CALCIUM PYROPHOSPHATE; CRYOPYRIN; INTERLEUKIN 1BETA; MEMBRANE RECEPTOR; PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MEMBRANE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; GOUT; HUMAN; INFLAMMATION; MACROPHAGE; MONOCYTE; NEUTROPHIL; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PSEUDOGOUT; REVIEW; TISSUE REACTION;

APOPTOSIS; ARTHRITIS, GOUTY; BIOLOGICAL MARKERS; CALCIUM PHOSPHATES; CARRIER PROTEINS; CHONDROCALCINOSIS; ENDOTHELIAL CELLS; GOUT; HUMANS; INFLAMMASOMES; INFLAMMATION; INTERLEUKIN-1BETA; MACROPHAGES; NEUTROPHILS; PROTEOLYSIS; TRANSFORMING GROWTH FACTOR BETA; URIC ACID;

EID: 84856597345     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Shi Y, Mucsi AD, Ng G. Monosodium urate crystals in inflammation and immunity. Immunol Rev 2010; 233: 203-17.
2. Zhang W, Doherty M, Bardin T, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 2011; 70: 563-70.
3. Zhang W, Doherty M, Pascual E, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis 2011; 70: 571-75.
4. Swan A, Heywood B, Chapman B, et al. Evidence for a causal relationship between the structure, size, and load of calcium pyrophosphate dihydrate crystals, and attacks of pseudogout. Ann Rheum Dis 1995; 54: 825-30.
5. Kippen I, Klinenberg JR, Weinberger A, Wilcox WR. Factors affecting urate solubility in vitro. Ann Rheum Dis 1974; 33: 313-7.
6. Ea HK, Nguyen C, Bazin D, et al. Articular cartilage calcification in osteoarthritis: insights into crystal-induced stress. Arthritis Rheum 2011; 63: 10-8.
7. Terkeltaub RA. Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol 2001; 281: C1-C11.
8. St Hilaire C, Ziegler SG, Markello TC, et al. NT5E mutations and arterial calcifications. N Engl J Med 2011; 364: 432-42.
9. Cailotto F, Bianchi A, Sebillaud S, et al. Inorganic pyrophosphate generation by transforming growth factor-beta-1 is mainly dependent on ANK induction by Ras/Raf-1/extracellular signal-regulated kinase pathways in chondrocytes. Arthritis Res Ther 2007; 9: R122.
10. Hirose J, Ryan LM, Masuda I. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum 2002; 46: 3218-29.
11. Busso N, So A. Mechanisms of inflammation in gout. Arthritis Res Ther 2010; 12: 206.
12. So A, Busso N. A magic bullet for gout? Ann Rheum Dis 2009; 68: 1517-9.
13. Martin WJ, Walton M, Harper J. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum 2009; 60: 281-9.
14. Getting SJ, Flower RJ, Parente L, et al. Molecular determinants of monosodium urate crystal-induced murine peritonitis: a role for endogenous mast cells and a distinct requirement for endothelial-derived selectins. J Pharmacol Exp Ther 1997; 283: 123-30.
15. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
16. Liu-Bryan R, Scott P, Sydlaske A, et al. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2005; 52: 2936-46.
17. Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 2005; 174: 5016-23.
18. Chen CJ, Shi Y, Hearn A, et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest 2006; 116: 2262-71.
19. Ng G, Sharma K, Ward SM, et al. Receptorindependent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 2008; 29: 807-18.
20. Popa-Nita O, Proulx S, Pare G, et al. Crystalinduced neutrophil activation: XI. Implication and novel roles of classical protein kinase C. J Immunol 2009; 183: 2104-14.
21. Popa-Nita O, Rollet-Labelle E, Thibault N, et al. Crystal-induced neutrophil activation. IX. Syk-dependent activation of class Ia phosphatidylinositol 3-kinase. J Leukoc Biol 2007; 82: 763-73.
22. Burt HM, Jackson JK, Rowell J. Calcium pyrophosphate and monosodium urate crystal interactions with neutrophils: effect of crystal size and lipoprotein binding to crystals. J Rheumatol 1989; 16: 809-17.
23. Terkeltaub R, Tenner AJ, Kozin F, Ginsberg MH. Plasma protein binding by monosodium urate crystals. Analysis by two-dimensional gel electrophoresis. Arthritis Rheum 1983; 26: 775-83.
24. Terkeltaub RA, Dyer CA. Martin J, Curtiss LK. Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. J Clin Invest 1991; 87: 20-6.
25. Terkeltaub RA, Santoro DA, Mandel G, Mandel N. Serum and plasma inhibit neutrophil stimulation by hydroxyapatite crystals. Evidence that serum alpha 2-HS glycoprotein is a potent and specific crystal-bound inhibitor. Arthritis Rheum 1988; 31: 1081-9.
26. Popa-Nita O, Naccache PH. Crystal-induced neutrophil activation. Immunol Cell Biol 2010; 88: 32-40.
27. Tramontini N, Huber C, Liu-Bryan R, et al. Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis. Arthritis Rheum 2004; 50: 2633-9.
28. Martinon F. Mechanisms of uric acid crystalmediated autoinflammation. Immunol Rev 2010; 233: 218-32.
29. Joosten LA, Netea MG, Fantuzzi G, et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum 2009; 60: 3651-62.
30. Joosten LA, Netea MG, Mylona E, et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum 2010; 62: 3237-48.
31. Martinon F, Petrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237-41.
32. So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007; 9: R28.
33. Nishimura A, Akahoshi T, Takahashi M, et al. Attenuation of monosodium urate crystalinduced arthritis in rabbits by a neutralizing antibody against interleukin-8. J Leukoc Biol 1997; 62: 444-9.
34. Terkeltaub R, Baird S, Sears P, et al. The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal-induced gouty synovitis. Arthritis Rheum 1998; 41: 900-9.
35. Hachicha M, Naccache PH, McColl SR. Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis. J Exp Med 1995; 182: 2019-25.
36. Ginsberg MH, Kozin F. Mechanisms of cellular interaction with monosodium urate crystals. IgG-dependent and IgG-independent platelet stimulation by urate crystals. Arthritis Rheum 1978; 21: 896-903.
37. Ortiz-Bravo E, Sieck MS, Schumacher HR Jr. Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum 1993; 36: 1274-85.
38. Landis RC, Yagnik DR, Florey O, et al. Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum 2002; 46: 3026-33.
39. Martin WJ, Shaw O, Liu X, et al. 2011. MSU crystal-recruited non-inflammatory monocytes differentiate into M1-like pro-inflammatory macrophages in a peritoneal murine model of gout. Arthritis Rheum 2011; 63: 1322-32.
40. Yagnik DR, Evans BJ, Florey O, et al. Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2004; 50: 2273-80.
41. Liote F, Prudhommeaux F, Schiltz C, et al. 1996 Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1. Arthritis Rheum 1996; 39: 1192-8.
42. Rose DM, Sydlaske AD, Agha-Babakhani A, et al. 2006. Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils. Arthritis Rheum 2006; 54: 3363-71.